(Photo=Wonyoung instagram) Kpop star Jang Wonyoung is accustomed to attracting attention for her appearance and fashion choices. Now, the 22-year-old singer is making headlines for something beyond her wardrobe. A recent social media post revealed an extravagant interior featuring a French designer sofa that can cost as much as $150,000 and an Italian audio system priced at $17,000. Wonyoung, a

Photo=Bank of Korea Central bank compensation offers a window into how major economies structure pay for officials whose interest-rate decisions influence global markets, borrowing costs and investment returns. For U.S. investors tracking monetary policy across Asia, South Korea’s central bank governor received substantially more reported compensation than Federal Reserve Chair Jerome Powell in 2025, though differences in how the institutions

Photo=Yongin government The race to build AI data centers is reshaping the semiconductor industry, pushing chipmakers to invest hundreds of billions of dollars in manufacturing capacity while developing new memory architectures to overcome data bottlenecks. For U.S. technology companies and investors, South Korea’s latest semiconductor announcements offer a window into two critical areas of competition: the scale of future chip

Photo=Motionelements The global semiconductor industry’s race to supply advanced memory for artificial intelligence is increasing the strategic value of technologies that help manufacturers test chips and maintain production quality. For U.S. semiconductor companies and investors, South Korea’s latest probe into alleged technology theft highlights a risk that extends beyond fabrication capacity and capital spending: the loss of proprietary engineering expertise

Photo=Hanmi Pharmaceutical South Korea’s obesity-drug market is emerging as a new battleground for price competition, with implications for U.S. pharmaceutical companies and investors betting on the long-term growth of GLP-1 treatments. Hanmi Pharmaceutical is preparing to launch Efe, a domestically developed weight-loss drug whose estimated first-month supply cost of about $90 could undercut established rivals from Eli Lilly and Novo